Search results

Order by most recent / most popular / relevance

Results: 1-10 of 17

Data protection in Canada: Court of Appeal confirms narrow approach

Torys LLP
-
Canada
-
January 30 2013

On January 18, 2013, the Federal Court of Appeal (FCA) released its decision in Takeda Canada Inc. v. The Minister of Health and Attorney General of

Canada’s PAAB releases updated Code of Advertising Acceptance

Torys LLP
-
Canada
-
December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Health Canada announces intent to develop a framework for orphan drug approval

Torys LLP
-
Canada, USA
-
October 5 2012

On October 3, 2012, Health Canada issued a press release announcing that it will develop a framework for the marketing approval of drugs to treat rare life-threatening, seriously debilitating or serious chronic rare diseases that are commonly referred to as "orphan drugs."

Canada to change the regulation of “food-like" natural health products

Torys LLP
-
Canada
-
April 24 2012

On April 17, 2012, Health Canada announced that it will classify and transition all "food-like" natural health products (NHPs) to the regulatory framework that governs the sale of food products in Canada

Health Canada’s guidance document on PM(NOC) Regulations now finalized

Torys LLP
-
Canada
-
April 4 2012

Health Canada has published an update to its guidance document on the application of the Patented Medicines (Notice of Compliance) Regulations

Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations

Torys LLP
-
Canada
-
October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations

Ontario companies doing business with hospitals may become subject to access-to-information requests

Torys LLP
-
Canada
-
April 6 2011

Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities

Canada amends regulations on adverse drug reaction reporting

Torys LLP
-
Canada
-
March 11 2011

Amended regulations regarding the reporting of adverse drug reactions came into force on February 10, 2011

Ontario government seeks appeal of pharmacies' successful challenge on private label restrictions

Torys LLP
-
Canada
-
February 24 2011

The regulation of private label drug products remains in flux with the recent decision of the Ontario Superior Court of Justice (Divisional Court) and potential appeal of that decision

Canadian and U.S. regulation of functional food claims

Torys LLP
-
Canada, USA
-
October 12 2010

In today's health-conscious marketplace, functional food labelling has grown into a multibillion dollar industry

next >